Skip to content

Welcome to Discover Pharma! Today is : November 12, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Atelerix signs deal with CliniSciences to expand access to cryo-free cell preservation in Europe and North Africa

    Atelerix has signed a new distribution agreement with CliniSciences that [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    N4 Pharma and SRI demonstrate targeted Nuvec delivery to lung cancer cells

    N4 Pharma has reported new data from its collaboration with [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    ReiThera: Commercial CDMO capabilities key to manage ‘volatile’ biotech market

    ReiThera will begin commercial production in 2026, a milestone the [...]

    May 5, 2026
  • Advanced Therapies,Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Gene therapy AMT-130 slows Huntington’s disease progression in early trial

    A gene therapy developed by uniQure appears to slow progression [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Poolbeg secures free supply of bispecific antibody for POLB 001 trial at The Christie

    Poolbeg Pharma has appointed Accelerating Clinical Trials (ACT) to run [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    REDCap Cloud 2.0 launched to harmonize clinical trial and real-world data for AI-driven research

    REDCap Cloud has launched version 2.0, a clinical trial data [...]

    May 5, 2026
  • Advanced Therapies,Digital & Data,Drug Discovery & Development

    AISB Network expands Federated OpenFold3 initiative with three new pharma contributors

    The AI Structural Biology (AISB) Network, powered by Apheris GmbH, [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    RION partners with Lonza to scale manufacturing of exosome-based therapeutics

    RION, a commercial and clinical-stage regenerative medicine company pioneering platelet-derived [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Merck opens climate-neutral €150 million filter manufacturing facility in Ireland

    Merck has inaugurated its first climate-neutral manufacturing facility in Ireland, [...]

    May 5, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Nanexa secures Japanese patent for PharmaShell technology

    Nanexa has received approval for a Japanese patent covering a [...]

    May 5, 2026
Previous495051Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • FDA issues Complete Response Letter for ITM-11 over manufacturing issues
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics
  • Grifols completes Phase 3 SPARTA study of Prolastin-C in alpha-1 emphysema
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
  • Novo Nordisk and AWS launch London AI hub to accelerate drug discovery
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top